Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2015 Jun 12

PMID 26064987

Citations 79

Authors

Stephanie Toth-Manikowski

Mohamed G Atta

Affiliations

Soon will be listed here.

Abstract

Diabetes is a worldwide epidemic that has led to a rise in diabetic kidney disease (DKD). Over the past two decades, there has been significant clarification of the various pathways implicated in the pathogenesis of DKD. Nonetheless, very little has changed in the way clinicians manage patients with this disorder. Indeed, treatment is primarily centered on controlling hyperglycemia and hypertension and inhibiting the renin-angiotensin system. The purpose of this review is to describe the current understanding of how the hemodynamic, metabolic, inflammatory, and alternative pathways are all entangled in pathogenesis of DKD and detail the various therapeutic targets that may one day play a role in quelling this epidemic.

Citing Articles

Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension.

Kanuparthy M, Manthana R, Kaushik H, Xiang K, Hamze J, Marimekala D Biomedicines. 2025; 13(2).

PMID: 40002822 PMC: 11853148. DOI: 10.3390/biomedicines13020409.

Serum Globulin and Albumin-to-Globulin Ratio are Associated with Diabetic Kidney Disease but Not Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study.

Zhang R, Jiao Y, Wu Y, Yan L, Zhang C, Xu J J Inflamm Res. 2024; 17:11545-11559.

PMID: 39737098 PMC: 11682941. DOI: 10.2147/JIR.S493681.

Gaining Insights Into Patients' Experiences of Remote Diagnostic Screening for Chronic Kidney Disease in Patients With Diabetes.

Deaney C, Reesby D J Patient Exp. 2024; 11:23743735241293624.

PMID: 39479588 PMC: 11523146. DOI: 10.1177/23743735241293624.

The early diagnostic value of serum renalase level in diabetic kidney disease and diabetic macroangiopathy: a retrospective case-control study.

Jin L, Wang W, Zhang R, Shen J, Li Y, Zhang Y Ther Adv Chronic Dis. 2024; 15:20406223241286677.

PMID: 39429975 PMC: 11487514. DOI: 10.1177/20406223241286677.

Novel Biomarkers for the diagnosis of diabetic nephropathy.

Concepcion M, Quiroz J, Suarez J, Paz J, Roseboom P, Ildefonso S Caspian J Intern Med. 2024; 15(3):382-391.

PMID: 39011442 PMC: 11246682. DOI: 10.22088/cjim.15.3.382.

References

Utimura R, Fujihara C, Mattar A, Malheiros D, Noronha I, Zatz R . Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int. 2002; 63(1):209-16. DOI: 10.1046/j.1523-1755.2003.00736.x. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Bolton W, Cattran D, Williams M, Adler S, Appel G, Cartwright K . Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol. 2003; 24(1):32-40. DOI: 10.1159/000075627. View

McCormick B, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G . The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis. Am J Kidney Dis. 2008; 52(3):454-63. DOI: 10.1053/j.ajkd.2008.01.025. View

Benz K, Amann K . Endothelin in diabetic renal disease. Contrib Nephrol. 2011; 172:139-148. DOI: 10.1159/000328695. View

Soma J, Sato K, Saito H, Tsuchiya Y . Effect of tranilast in early-stage diabetic nephropathy. Nephrol Dial Transplant. 2006; 21(10):2795-9. DOI: 10.1093/ndt/gfl325. View

Lee W, Chen H, Wang C, Lin P, Ou T, Chen C . Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB. Biosci Biotechnol Biochem. 2010; 74(7):1355-61. DOI: 10.1271/bbb.90938. View

Kramer H, Nguyen Q, Curhan G, Hsu C . Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003; 289(24):3273-7. DOI: 10.1001/jama.289.24.3273. View

Kim Y, Ahn Y, Hong M, Joo S, Kim K, Sohn I . Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol. 2007; 50(1):41-9. DOI: 10.1097/FJC.0b013e31805559b9. View

10.

Tang W, Lin F, Lee C, Kuo F, Hsieh C, Hsiao F . Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial. Endocrine. 2013; 45(2):293-301. DOI: 10.1007/s12020-013-0002-3. View

11.

Navarro J, Milena F, Mora C, Leon C, Garcia J . Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol. 2006; 26(6):562-70. DOI: 10.1159/000098004. View

12.

Mason R . Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?. J Cell Commun Signal. 2009; 3(2):95-104. PMC: 2721079. DOI: 10.1007/s12079-009-0038-6. View

13.

Thomas M, MacIsaac R, Jerums G, Weekes A, Moran J, Shaw J . Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care. 2009; 32(8):1497-502. PMC: 2713618. DOI: 10.2337/dc08-2186. View

14.

Friedman A, Chambers M, Kamendulis L, Temmerman J . Short-term changes after a weight reduction intervention in advanced diabetic nephropathy. Clin J Am Soc Nephrol. 2013; 8(11):1892-8. PMC: 3817909. DOI: 10.2215/CJN.04010413. View

15.

Prabhakar S . Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004; 24(4):333-44. DOI: 10.1016/j.semnephrol.2004.04.005. View

16.

Watson A, Li J, Schumacher C, de Gasparo M, Feng B, Thomas M . The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia. 2009; 53(1):192-203. DOI: 10.1007/s00125-009-1540-3. View

17.

Tufro A, Veron D . VEGF and podocytes in diabetic nephropathy. Semin Nephrol. 2012; 32(4):385-93. PMC: 3438453. DOI: 10.1016/j.semnephrol.2012.06.010. View

18.

Krairittichai U, Mahannopkul R, Bunnag S . An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease. J Med Assoc Thai. 2012; 95 Suppl 3:S41-7. View

19.

Kanai Y, Lee W, You G, Brown D, Hediger M . The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest. 1994; 93(1):397-404. PMC: 293794. DOI: 10.1172/JCI116972. View

20.

Hoekman J, Lambers Heerspink H, Viberti G, Green D, Mann J, de Zeeuw D . Predictors of congestive heart failure after treatment with an endothelin receptor antagonist. Clin J Am Soc Nephrol. 2014; 9(3):490-8. PMC: 3944766. DOI: 10.2215/CJN.07040713. View